Ananth Kadambi

Jul 15, 2024 | ascpt.onlinelibrary.wiley.com | Mohamed Kamal |Samit Ganguly |Ananth Kadambi |Patrick Smith

CONFLICTS OF INTEREST The authors declared no competing interests for this work. 1Shaw, D.L., Dhruva, S.S. & Ross, J.S. Coverage of novel therapeutic agents by medicare prescription drug plans following FDA approval. J. Manag. Care Spec. Pharm. 24, 1230–1238 (2018). 2Hill-McManus, D., Marshall, S., Liu, J., Willke, R.J. & Hughes, D.A. Linked pharmacometric-pharmacoeconomic modeling and simulation in clinical drug development. Clin. Pharmacol. Ther. 110, 49–63 (2021). 3Kamal, M.A. et al.